Dural Invasion Predicts the Laterality and Development of Neck Metastases in Esthesioneuroblastoma
Overview
Authors
Affiliations
Neck metastases in patients with esthesioneuroblastoma (ENB) constitute the most significant predictor of poor long-term survival. Recently, researchers discovered the existence of dural lymphatic channels that drain to the cervical lymph nodes. From this physiologic basis, we hypothesized that patients with ENB who develop dural invasion (DI) would exhibit a proclivity for neck metastases. Retrospective review. Tertiary referral center. All patients treated for ENB from January 1, 1994 to December 31, 2015. Incidence, laterality, and recurrence rate of neck metastases by DI status. Sixty-one patients were identified (38% female; median age 49, range, 10-80), 34 (56%) of whom had DI and 27 (44%) did not. Of patients with DI, 50% presented with or developed neck disease following treatment compared with just 22% of those without DI ( = 0.026). Bilateral neck disease was more common in patients with DI (11/34, 32%) compared with those without (2/27, 7%) ( = 0.018). Five-year regional recurrence-free survival rates were 88% for those without and 64% for those with DI ( = 0.022). Kadish C patients with DI were more likely to develop regional recurrence when compared with Kadish C without DI and Kadish A/B ( = 0.083). Further, Kadish C patients with DI displayed worse overall survival than Kadish C without DI and Kadish A/B. Kadish D patients displayed the worst overall survival. The difference in overall survival among these four groups was significant ( < 0.001). DI by ENB is associated with increased incidence of cervical nodal metastases, bilateral neck disease, worse regional recurrence-free survival, and poorer overall survival. These data support the division of Kadish C by DI status.
Hong S, Park S, Kim J, Heo S, Cho S, Won T Clin Exp Otorhinolaryngol. 2024; 17(2):137-146.
PMID: 38404243 PMC: 11151001. DOI: 10.21053/ceo.2023.00089.
Update on olfactory neuroblastoma.
Lopez F, Agaimy A, Franchi A, Suarez C, Vander Poorten V, Makitie A Virchows Arch. 2024; 484(4):567-585.
PMID: 38386106 DOI: 10.1007/s00428-024-03758-z.
Esthesioneuroblastoma: Management of the N0 neck.
Youssef S, Farrell N J Neurol Surg Rep. 2023; 84(3):e85-e86.
PMID: 37564630 PMC: 10411164. DOI: 10.1055/s-0043-1770965.
The contemporary management of cancers of the sinonasal tract in adults.
Thawani R, Kim M, Arastu A, Feng Z, West M, Taflin N CA Cancer J Clin. 2022; 73(1):72-112.
PMID: 35916666 PMC: 9840681. DOI: 10.3322/caac.21752.
Lechner M, Takahashi Y, Turri-Zanoni M, Liu J, Counsell N, Hermsen M Eur J Cancer. 2022; 162:221-236.
PMID: 34980502 PMC: 9554673. DOI: 10.1016/j.ejca.2021.09.046.